Rhythm Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$89.67(as of Jul 10, 10:04 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Rhythm Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$89.67
Ticker SymbolRYTM
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees283
CountyUSA
Market Cap$4,070.9M
EBIDTA-263.9M
10-Day Moving Average66.83
P/E Ratio-20.93
20-Day Moving Average65.00
Forward P/E Ratio0.00
50-Day Moving Average63.49
Earnings per Share-4.34
200-Day Moving Average57.48
Profit Margin-103.50%
RSI82.22
Shares Outstanding63.60M
ATR3.83
52-Week High68.58
Volume4,790,494
52-Week Low35.17
Most Recent Support Level64.65
Book Value164.5M
Most Recent Resistance Level67.75
P/B Ratio33.32
Upper Keltner73.61
P/S Ratio42.13
Lower Keltner56.40
Debt-to-Equity Ratio73.61
Next Earnings Date08/05/2025
Cash Surplus-26.4M
Next Ex-Dividend DateUnknown

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.